drugset / Trial / NCT02232542
Tolerability and Safety of Duloxetine BID in Healthy Female Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
Study to assess the safety and tolerability of 100 mg of duloxetine BID compared to 40 mg of duloxetine BID or placebo for 7 days
Timeline
- Start
- 2003-06
- Primary completion
- 2003-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Duloxetine | Small molecule | 40 mg | — |
| Subject | Duloxetine | Small molecule | 100 mg | — |
Indications
No indication recorded.